Nisun International Enters Strategic Partnership with Beijing Tong Ren Tang to Source Traditional Chinese Medicine Ingredients
Nisun International (Nasdaq: NISN) has entered a strategic partnership with Beijing Tong Ren Tang Henan Traditional Chinese Medicine Technology Development to source ingredients for traditional Chinese medicine (TCM), focusing initially on Cornus officinalis. This marks Nisun's entry into the TCM supply chain, leveraging its expertise to ensure authenticity and quality of ingredients in the rapidly growing health sector.
The company plans to expand its sourcing efforts to include other essential TCM ingredients, establishing itself as a trusted provider in this market. Additionally, Nisun has initiated share repurchases under its recently announced $15 million buyback program, demonstrating confidence in its long-term growth prospects and commitment to enhancing shareholder value.
Nisun International (Nasdaq: NISN) ha intrapreso una partnership strategica con Beijing Tong Ren Tang Henan Traditional Chinese Medicine Technology Development per la fornitura di ingredienti per la medicina tradizionale cinese (MTC), concentrandosi inizialmente su Cornus officinalis. Questo segna l'ingresso di Nisun nella filiera della MTC, sfruttando la propria esperienza per garantire l'autenticità e la qualità degli ingredienti nel settore della salute in rapida crescita.
L'azienda prevede di ampliare i propri sforzi di approvvigionamento per includere altri ingredienti essenziali per la MTC, affermandosi come un fornitore di fiducia in questo mercato. Inoltre, Nisun ha avviato programmi di riacquisto di azioni nell'ambito del suo recentemente annunciato programma di riacquisto da 15 milioni di dollari, dimostrando fiducia nelle proprie prospettive di crescita a lungo termine e impegno a migliorare il valore per gli azionisti.
Nisun International (Nasdaq: NISN) ha entrado en una asociación estratégica con Beijing Tong Ren Tang Henan Traditional Chinese Medicine Technology Development para obtener ingredientes para la medicina tradicional china (MTC), enfocándose inicialmente en Cornus officinalis. Esto marca la entrada de Nisun en la cadena de suministro de MTC, aprovechando su experiencia para garantizar la autenticidad y calidad de los ingredientes en el sector de la salud de rápido crecimiento.
La compañía planea expandir sus esfuerzos de abastecimiento para incluir otros ingredientes esenciales de MTC, estableciéndose como un proveedor confiable en este mercado. Además, Nisun ha iniciado recompra de acciones bajo su recientemente anunciado programa de recompra de 15 millones de dólares, demostrando confianza en sus perspectivas de crecimiento a largo plazo y compromiso con la mejora del valor para los accionistas.
니선 인터내셔널 (Nasdaq: NISN)은 베이징 통렌탕 허난 전통 한약 기술 개발과 전략적 파트너십을 체결하여 전통 중국 의학 (TCM)을 위한 재료 조달에 나섰으며, 초기에는 Cornus officinalis에 집중하고 있습니다. 이는 니선이 TCM 공급망에 진입하는 것으로, 빠르게 성장하는 건강 산업에서 재료의 진품성과 품질을 보장하기 위해 노하우를 활용합니다.
회사는 다른 필수 TCM 재료를 포함하도록 조달 노력을 확장할 계획이며, 이 시장에서 신뢰할 수 있는 공급업체로 자리 잡기를 원합니다. 또한, 니선은 최근 발표한 1500만 달러의 자사주 매입 프로그램에 따라 자사주 매입을 시작했습니다, 이는 장기 성장 전망에 대한 신뢰와 주주 가치를 향상시키려는 의지를 보여줍니다.
Nisun International (Nasdaq: NISN) a établi un partenariat stratégique avec Beijing Tong Ren Tang Henan Traditional Chinese Medicine Technology Development pour se procurer des ingrédients pour la médecine traditionnelle chinoise (MTC), en se concentrant initialement sur Cornus officinalis. Cela marque l'entrée de Nisun dans la chaîne d'approvisionnement de la MTC, tirant parti de son expertise pour garantir l'authenticité et la qualité des ingrédients dans le secteur de la santé en pleine croissance.
L'entreprise prévoit d'élargir ses efforts d'approvisionnement pour inclure d'autres ingrédients essentiels de la MTC, s'établissant comme un fournisseur de confiance sur ce marché. De plus, Nisun a initié des rachats d'actions dans le cadre de son programme de rachat de 15 millions de dollars récemment annoncé, démontrant sa confiance dans ses perspectives de croissance à long terme et son engagement à améliorer la valeur pour les actionnaires.
Nisun International (Nasdaq: NISN) hat eine strategische Partnerschaft mit Beijing Tong Ren Tang Henan Traditional Chinese Medicine Technology Development geschlossen, um Zutaten für die traditionelle chinesische Medizin (TCM zu beziehen), wobei der Fokus zunächst auf Cornus officinalis liegt. Dies markiert Nisuns Eintritt in die TCM-Lieferkette, wobei das Unternehmen seine Expertise nutzt, um die Echtheit und Qualität der Zutaten im schnell wachsenden Gesundheitssektor zu gewährleisten.
Das Unternehmen plant, seine Beschaffungsbemühungen auf weitere essentielle TCM-Zutaten auszudehnen und sich als vertrauenswürdiger Anbieter auf diesem Markt zu etablieren. Darüber hinaus hat Nisun Aktienrückkäufe eingeleitet im Rahmen seines kürzlich angekündigten 15-Millionen-Dollar-Rückkaufprogramms, was Vertrauen in seine langfristigen Wachstumsaussichten und das Engagement zur Verbesserung des Aktionärswertes demonstriert.
- Strategic partnership with Beijing Tong Ren Tang to enter the traditional Chinese medicine supply chain
- Expansion into the rapidly growing health sector
- Initiation of share repurchases under a $15 million buyback program
- Plans to broaden sourcing efforts for other essential TCM ingredients
- None.
Insights
This strategic partnership marks a significant expansion for Nisun International into the traditional Chinese medicine (TCM) supply chain. The collaboration with Beijing Tong Ren Tang, a renowned TCM company, positions Nisun to capitalize on the growing demand for verified TCM ingredients. Focusing initially on Cornus officinalis sourcing demonstrates a targeted approach to enter this specialized market.
The TCM industry's emphasis on ingredient authenticity aligns well with Nisun's supply chain expertise, potentially creating a competitive advantage. This move diversifies Nisun's portfolio and taps into China's substantial healthcare sector, where TCM plays a important role. The company's plans to expand into sourcing other TCM ingredients suggest a long-term commitment to this vertical.
However, entering a highly regulated and specialized market like TCM comes with challenges, including strict quality control requirements and potential regulatory hurdles. Nisun will need to demonstrate its ability to meet these stringent standards consistently to succeed in this new venture.
Nisun International's strategic moves signal a positive outlook for the company's financial future. The expansion into the TCM supply chain opens up a new revenue stream in a growing market, potentially boosting the company's top-line growth. This diversification can help mitigate risks associated with overreliance on existing business segments.
Notably, the initiation of share repurchases under the
Investors should monitor the execution of both the TCM partnership and the buyback program, as successful implementation could lead to improved financial performance and increased shareholder value. However, it's important to assess the impact on cash flows and ensure that these initiatives don't strain the company's financial resources.
Company Initiates Share Repurchases Under
This cooperation highlights Nisun's commitment to entering the TCM industry, which emphasizes stringent verification and validation of ingredients to ensure authenticity and quality. The partnership opens new doors for Nisun to expand into the rapidly growing health sector, leveraging its supply chain capabilities. TCM remains a pillar of
In addition to this strategic move, Nisun has also initiated share repurchases under its recently announced
"We are excited to expand our supply chain services into the traditional Chinese medicine industry," said Mr. Xin Liu, CEO of Nisun International. "This partnership with Tong Ren Tang not only allows us to provide high-quality, validated TCM products but also strengthens our position in the health sector. We see significant growth potential in expanding our supply chain offerings, which will drive sustainable value for our shareholders."
By entering the TCM supply chain and beginning share repurchases, Nisun is positioning itself for growth, ensuring quality and transparency for consumers while enhancing returns for investors.
About Nisun International Enterprise Development Group Co., Ltd.
Nisun International Enterprise Development Group Co., Ltd. (NASDAQ: NISN) is a technology-driven, integrated supply chain solutions provider focused on transforming the corporate finance industry. Leveraging its industry experience, Nisun International is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, Nisun International provides users with professional solutions for technology supply chain management, technology asset routing, and digital transformation of tech and finance institutions, enabling the industry to strengthen and grow. At the same time, Nisun International continues to deepen the field of industry segmentation through industrial and financial integration. Focusing on industry-finance linkages, Nisun International aims to serve the upstream and downstream of the industrial supply chain while also assisting with supply-side sub-sector reform. For more information, please visit http://ir.nisun-international.com/
Cautionary Note Regarding Forward-Looking Statements
This press release contains information about Nisun International 's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. Nisun International encourages you to review other factors that may affect its future results in Nisun International 's registration statement and in its other filings with the Securities and Exchange Commission. Nisun International assumes no obligation to update or revise its forward-looking statements as a result of new information, future events or otherwise, except as expressly required by applicable law.
Contacts
Nisun International Enterprise Development Group Co., Ltd
Investor Relations
Tel: +86 (21) 2357-0055
Email: ir@cnisun.com
View original content:https://www.prnewswire.com/news-releases/nisun-international-enters-strategic-partnership-with-beijing-tong-ren-tang-to-source-traditional-chinese-medicine-ingredients-302282765.html
SOURCE Nisun International Enterprise Development Group Co., Ltd
FAQ
What is Nisun International's new strategic partnership for TCM ingredients?
How is Nisun International (NISN) expanding its business?
What recent action has Nisun International taken regarding its stock?
What is the significance of Nisun's partnership with Beijing Tong Ren Tang?
